Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-09-22
1998-09-15
Burn, Brian M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
604 4, 604 5, 514885, 514908, A61K 3140
Patent
active
058078819
ABSTRACT:
Multiple sclerosis and rheumatoid arthritis can be treated effectively using photodynamic therapy. In this protocol, a photoactive compound is administered, allowed to distribute in the effected subject, and the subject is then irradiated to activate the photoactive compound. Alternatively, the blood of a subject to be treated can be subjected to PDT extracorporeally. In the case of rheumatoid arthritis, localized treatment at the joints may also be employed.
REFERENCES:
patent: 4610241 (1986-09-01), Gordon
patent: 4878891 (1989-11-01), Judy et al.
patent: 4960408 (1990-10-01), Klainer et al.
patent: 5028594 (1991-07-01), Carson
patent: 5095030 (1992-03-01), Levy et al.
patent: 5368841 (1994-11-01), Trauner et al.
patent: 5430051 (1995-07-01), Aizawa et al.
Capra et al., "Significantly Higher Levels of Soluble Interleukin 2 in Patients with Relapsing-Remitting Multiple Sclerosis Compared with Helathy Subjects", Arch. Neurol., vol. 46, p. 254 (1990).
Chowdhary et al., "The Use of Transcutaneous Photodynamic Therapy in the Prevention of Adjuvant-Enhanced Arthritis in MRL/lpr Mice", Clin. Immun. and Immunopath., vol. 72:2, pp. 255-263 (1994).
Edelson, "Photopheresis: A New Therapeutic Concept", Yale J. of Biol. and Med., vol. 62, pp. 565-577 (1989).
Levy et al., "Immunomodulatory Effects of PDT Using BPD", Photochem. and Photobiol., vol. 59, p. 75 (1994).
North et al., "Photosensitizers as Virucidal Agents", J. Photochem. Photobiol B.: Biol.,, vol. 17, pp. 99-108 (1993).
Obochi et al., "Targeting Activated Lymphocytes with Photodynamic Therapy: Susceptibility of Mitogen-Stimulated Splenic Lymphocytes to Benzoporphyrin Derivative (BPD) Photosensitization", Photochem. and Photobiol., vol. 62:1, pp. 169-175 (1995).
Qin et al., "Enhanced Skin Allograft Survival After Photodynamic Therapy", Transplantation, vol. 56:6, pp. 1481-1486 (1993).
Ratkay et al., "Photodynamic Therapy: A Comparison with Other Immunomodulatory Treatments of Adjuvant-Enhanced Arthritis in MRL-lpr Mice", Clin. Exp. Immunol., vol. 95, pp. 373-377 (1994).
Richter et al., "Non-Oncologic Potentials for Photodynamic Therapy", Proceedings of Photodynamic Therapy of Cancer, Budapest, Hungary (1-4 Sep. 1993).
Zarling et al., J. Immunol. (1990) 144:2992-2998.
Zuckerman et al., Treatment of Antigen-induced Arthritis in Rabbits with Dysprosium-165-Ferric Hydroxide Macroaggregates, J. of Orthopaedic Res., 7:50-60 (1989).
Gruner et al., "Inhibition of HLA-DR Antigen Expression and of the Allogeneic Mixed Leukocyte Reaction by Photochemical Treatment", Tissue Antigens 27, 147 and 151-54 (1986).
North et al., "Photodynamic Inactivation of Retrovirus by Benzoporphyrin Derivative: a Feline Leukemia Virus Model", Transfusion 32, 121-28 (1992).
North et al., "Photoinactivation of Human Immunodeficiency Virus (HIV) by Benzoporphyrin Derivative", Cell Biochem., Supp., Part E, 85, Abstract Q 545 (1992); and.
Matthews et al., "Preliminary Studies of Photoinactivation of Human Immunodeficiency Virus in Blood", Transfusion 31, 636-41 (1991).
Chan Agnes How-Ching
Hunt David William Carey
Leong Simon
Levy Julia
Renke Martin
Burn Brian M.
Quadra Logic Technologies Inc.
University of British Columbia
LandOfFree
Method for selectively reducing activated leukocyte cell populat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for selectively reducing activated leukocyte cell populat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for selectively reducing activated leukocyte cell populat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-87852